Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
Learn More Breathe Better - A long-acting muscarinic antagonist (LAMA) is a medicine that may help control asthma long-term. Download this fact sheet to learn more about LAMAs and how they're used:
Does my patient still need A long-acting inhaler? — PDC Rx
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Long-Acting Muscarinic Antagonists (LAMAs) For Asthma
Key findings of recent LAMA and dual-agent LAMA/LABA trials reviewed. | Download Table
LAMA - "Long-Acting Muscarinic Antagonists" by AcronymsAndSlang.com
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease - ScienceDirect
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment | European Respiratory Society
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
Understanding the role of long-acting muscarinic antagonists in asthma treatment - ScienceDirect
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar